324 related articles for article (PubMed ID: 2842714)
1. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus.
Ben David Y; Prideaux VR; Chow V; Benchimol S; Bernstein A
Oncogene; 1988 Aug; 3(2):179-85. PubMed ID: 2842714
[TBL] [Abstract][Full Text] [Related]
2. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
[TBL] [Abstract][Full Text] [Related]
3. Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia.
Munroe DG; Rovinski B; Bernstein A; Benchimol S
Oncogene; 1988 Jun; 2(6):621-4. PubMed ID: 3290808
[TBL] [Abstract][Full Text] [Related]
4. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias.
Moreau-Gachelin F; Tavitian A; Tambourin P
Nature; 1988 Jan; 331(6153):277-80. PubMed ID: 2827041
[TBL] [Abstract][Full Text] [Related]
5. Spi-1 oncogene activation in Rauscher and Friend murine virus-induced acute erythroleukemias.
Moreau-Gachelin F; Ray D; de Both NJ; van der Feltz MJ; Tambourin P; Tavitian A
Leukemia; 1990 Jan; 4(1):20-3. PubMed ID: 2153262
[TBL] [Abstract][Full Text] [Related]
6. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
7. Friend virus induced murine erythroleukaemia: the p53 locus.
Johnson P; Benchimol S
Cancer Surv; 1992; 12():137-51. PubMed ID: 1638545
[TBL] [Abstract][Full Text] [Related]
8. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
Prasher JM; Elenitoba-Johnson KS; Kelley LL
Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
[TBL] [Abstract][Full Text] [Related]
9. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
10. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus.
Lavigueur A; Bernstein A
Oncogene; 1991 Dec; 6(12):2197-201. PubMed ID: 1766668
[TBL] [Abstract][Full Text] [Related]
11. Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias.
Dreyfus F; Sola B; Fichelson S; Varlet P; Charon M; Tambourin P; Wendling F; Gisselbrecht S
Leukemia; 1990 Aug; 4(8):590-4. PubMed ID: 2143796
[TBL] [Abstract][Full Text] [Related]
12. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
Howard J; Ung Y; Adachi D; Ben-David Y
Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
[TBL] [Abstract][Full Text] [Related]
13. Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes.
Chow V; Ben-David Y; Bernstein A; Benchimol S; Mowat M
J Virol; 1987 Sep; 61(9):2777-81. PubMed ID: 3302314
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
[TBL] [Abstract][Full Text] [Related]
15. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias.
Moreau-Gachelin F; Ray D; Mattei MG; Tambourin P; Tavitian A
Oncogene; 1989 Dec; 4(12):1449-56. PubMed ID: 2594367
[TBL] [Abstract][Full Text] [Related]
16. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
17. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity.
Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y
Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856
[TBL] [Abstract][Full Text] [Related]
18. Sequences of polycythemia-type Friend spleen focus-forming virus in clone-745-derived mouse erythroleukemia cells.
Scher W; Jing Y; Lu M; Bishop DF; Scher BM
Arch Virol; 2009; 154(5):895-8. PubMed ID: 19347245
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of helper virus replication in the presence of defective retrovirus.
Anand R; Steeves RA; Lilly F
Microbios; 1989; 58(235):71-82. PubMed ID: 2544787
[TBL] [Abstract][Full Text] [Related]
20. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
Rovinski B; Benchimol S
Oncogene; 1988 May; 2(5):445-52. PubMed ID: 3287278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
